组成性雄激素受体活性维持三阴性乳腺癌中的DNA复制程序
Constitutive androgen receptor activity sustains DNA replication programs in triple-negative breast cancer
Li Jing, Yuan Hongwei, Chen Kefan, Peng Jian, Du Wu, Li Xinghai
Journal:Cell Death & Disease
IF:12.2
DOI:10.1038/s41419-026-09180-4
PMID:
Published:2026-08-06
research field:神经科学分子生物学进化生物学植物育种遗传学
Abstract
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking effective targeted therapies. Despite AR expression in nearly half of TNBCs, androgen receptor signaling inhibitors (ARSIs) have shown minimal clinical benefit. In this study, we utilized HP518, a potent PROTAC that selectively degrades AR, to interrogate the role of AR in TNBC. We uncover a non-canonical, androgen-independent function of AR in AR-positive TNBC cells: AR cooperates with transcriptional regulators FoxA1 and GATA3 to promote expression of DNA replication genes critical for tumor proliferation. Genetic and pharmacological degradation of AR suppresses tumor cell growth, downregulates key DNA replication genes, and disrupts AR-associated transcriptional complexes. In AR-positive TNBC patient-derived xenografts (PDX), HP518 robustly inhibits tumor growth and synergizes with PI3Kα inhibition and chemotherapy. Our findings identify a previously unappreciated mechanism of AR action in TNBC and support AR degradation-not antagonism as a rational therapeutic strategy.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


